Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
01/16/2013 | CN102884047A 2-pyridone compounds |
01/16/2013 | CN102884044A Derivatives of aminoindanes, their preparation and their application in therapeutics |
01/16/2013 | CN102875538A Method for preparing vilazodone or hydrochloride thereof |
01/16/2013 | CN102875537A Novel preparation method of antithrombosis medicine |
01/16/2013 | CN102875536A Halamine antibacterial agent and synthetic method and application thereof |
01/16/2013 | CN102875503A C-glucoside derivative |
01/16/2013 | CN102875441A Plexxikon inc |
01/16/2013 | CN102875273A Synthetic method of heteroaryl ether |
01/16/2013 | CN102872001A Compound serving as PPAR gamma ligand and application thereof |
01/16/2013 | CN101921236B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
01/16/2013 | CN101899011B Dithiocarbamates compound, preparation method and application thereof |
01/16/2013 | CN101711244B 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
01/16/2013 | CN101678129B Radioactive pet agents for imaging CCR5 in vivo |
01/15/2013 | US8354542 Heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device |
01/15/2013 | US8354435 Modulators of aldehyde dehydrogenase activity and methods of use thereof |
01/15/2013 | US8354423 Insecticidal spironindane derivatives |
01/15/2013 | US8354410 Compounds for the treatment of hepatitis C |
01/15/2013 | US8354399 Substituted indazole derivatives active as kinase inhibitors |
01/15/2013 | US8354397 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
01/15/2013 | CA2702834C Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
01/15/2013 | CA2547391C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
01/10/2013 | WO2013006738A1 Compounds for the treatment of hiv |
01/10/2013 | WO2013006308A2 Dihydropyrazoles |
01/10/2013 | WO2013004965A1 Novel combination of n-hydroxy-4-{2-[3-(n,n-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamide and folfox |
01/10/2013 | WO2013004709A1 Indolylmaleimides as soft pan-pkc inhibitors |
01/10/2013 | WO2013004332A1 Substituted azaheterocycles for the treatment of cancer |
01/10/2013 | WO2013004092A1 3-oxo-3, 4-dihydro-2-pyrazineformamide derivatives, pharmaceutical compositions, preparation methods and uses thereof |
01/10/2013 | WO2012101065A3 Pyrimidine biaryl amine compounds and their use as cdk9 inhibitors |
01/10/2013 | WO2012085665A3 Novel processes for preparing triazolo[4,5-d]pyrimidine derivatives and intermediates thereof |
01/10/2013 | US20130012715 Pyrazole synthesis by coupling of carboxylic acid derivatives and enamines |
01/10/2013 | US20130012713 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
01/10/2013 | US20130012709 NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES |
01/10/2013 | US20130012704 Compounds and compositions as protein kinase inhibitors |
01/10/2013 | US20130012692 Sodium channel blockers |
01/10/2013 | US20130012547 Insecticidal compounds |
01/10/2013 | US20130012543 Cytoskeletal active rho kinase inhibitor compounds, composition and use |
01/10/2013 | US20130012541 Therapeutic Agents Useful for Treating Pain |
01/10/2013 | US20130012532 Cyclopropanecarboxylic acid derivative |
01/10/2013 | US20130012530 New Positive allosteric modulators of nicotinic acetylcholine receptor |
01/10/2013 | US20130012512 P38 MAP kinase inhibitors |
01/10/2013 | US20130012490 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
01/10/2013 | US20130012381 Pyridazine Compounds for Controlling Invertebrate Pests |
01/10/2013 | US20130009543 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device |
01/10/2013 | CA2840883A1 Substituted azaheterocycles for the treatment of cancer |
01/10/2013 | CA2840095A1 Compounds for the treatment of hiv |
01/10/2013 | CA2837524A1 Dihydropyrazoles |
01/09/2013 | EP2543666A1 Radioactive iodine labeled organic compound or salt thereof |
01/09/2013 | EP2542545A1 Inhibitors of hepatitis c virus ns5b polymerase |
01/09/2013 | EP2542539A1 Tetrazole compounds which selectively modulate the cb2 receptor |
01/09/2013 | EP2542538A1 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides |
01/09/2013 | EP2542528A1 Heterocyclic amides as rock inhibitors |
01/09/2013 | EP2542524A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
01/09/2013 | EP2542089A1 Nuclear transport modulatiors and uses thereof |
01/09/2013 | CN102869666A Heterocyclic inhibitors of histamine receptors for the treatment of disease |
01/09/2013 | CN102869659A Bicarbazole containing compounds for OLEDs |
01/09/2013 | CN102869658A Modulators of fatty acid amide hydrolase |
01/09/2013 | CN102869657A Analogues for the treatment or prevention of flavivirus infections |
01/09/2013 | CN102863512A Novel antiviral compound |
01/09/2013 | CN102863446A Preparation of pyrrole and pyrrolin fused ring compound with insecticidal activity and use thereof |
01/09/2013 | CN102863432A Modulators of cftr |
01/09/2013 | CN102863431A Preparation method of posaconazole |
01/09/2013 | CN102863430A Preparation method of sesquiterpenes saussurea lappa clarke alkaloid monomer |
01/09/2013 | CN102863429A Preparation method of acrimarine F |
01/09/2013 | CN102863428A Spiro-compounds taken as hepatitis c virus (HCV) inhibitor |
01/09/2013 | CN102153508B 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone and application of the 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone in preparing antitumour drugs |
01/09/2013 | CN101798298B Imidazole derivatives |
01/09/2013 | CN101711243B 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
01/09/2013 | CN101616668B New pharmaceutical composition |
01/09/2013 | CN101481374B Method for removing trityl group of 1-trityl-5-(1,1'-biphenylyl-2 yl)-1H-tetrazole compound |
01/09/2013 | CN101400655B Quinolone derivative or pharmaceutically acceptable salt thereof |
01/09/2013 | CN101233127B Heterocyclic compound and organic electroluminescent device using same |
01/08/2013 | US8350041 Tricyclic δ-opioid modulators |
01/08/2013 | US8350026 VEGF-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof |
01/08/2013 | US8349870 Fungicidal hetercyclic compounds |
01/08/2013 | US8349867 Quinoline compounds, intermediates, preparation methods and uses thereof |
01/08/2013 | US8349859 Pyrimidine derivatives |
01/08/2013 | US8349843 Carboxylic acid derivatives, their preparation and use |
01/08/2013 | US8349834 Dioxolane derivates for the treatment of cancer |
01/08/2013 | US8349829 [4-(1-amino-ethyl)-cyclohexyl]-methyl-amine and [6-(1-amino-ethyl)-tetrahydro-pyran-3-yl]-methyl-amine derivatives as antibacterials |
01/08/2013 | CA2677315C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases |
01/08/2013 | CA2642668C Indole-3-carboxylic acid amide and ester compounds bearing phenyl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
01/08/2013 | CA2596735C Crystal of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1- methylpyridin-2(1h)-one and processes for producing the same |
01/08/2013 | CA2567574C Benzotriazine inhibitors of kinases |
01/08/2013 | CA2562571C Novel androgens |
01/08/2013 | CA2557372C Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
01/08/2013 | CA2480578C Anomeric derivatives of monosaccharides |
01/08/2013 | CA2478731C Carbamates as hiv protease inhibitors |
01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
01/03/2013 | WO2013002357A1 Hiv replication inhibitor |
01/03/2013 | WO2013000994A1 Novel inhibitor compounds of phosphodiesterase type 10a |
01/03/2013 | WO2012148140A3 Imidazole-based alkaloid derivatives which have angiogenesis inhibition and antioxidant effects and production method thereof |
01/03/2013 | US20130005993 Novel diaryl sulfone compound, and manufacturing method for same |
01/03/2013 | US20130005971 Process and Intermediates for Preparing Lapatinib |
01/03/2013 | US20130005965 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
01/03/2013 | US20130005964 Sulfonyl amide derivatives for the treatment of abnormal cell growth |
01/03/2013 | US20130005937 Novel method for preparing polyols and products obtained |
01/03/2013 | US20130005767 Therapeutic compounds |
01/03/2013 | US20130005710 Aminopyridine derivative |
01/03/2013 | US20130005705 Novel inhibitor compounds of phosphodiesterase type 10a |
01/03/2013 | US20130005675 Quinolone compound and pharmaceutical composition |